Edoardo Cignoli : Pfizer Lung Cancer Treatment Misses Goals

Pfizer Inc.'s treatment for advanced nonsmall cell lung cancer didn't meet goals in two Phase III studies. Both trials evaluated the therapy, called dacomitinib, in populations of previously treated patients.



via WSJ.com: US Business http://ift.tt/LebbCj